Franz X Kleber
Overview
Explore the profile of Franz X Kleber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rissanen T, Kleber F, Scheller B
Catheter Cardiovasc Interv
. 2023 Sep;
102(5):912-913.
PMID: 37731291
No abstract available.
2.
Kleber F
Catheter Cardiovasc Interv
. 2023 Jul;
102(4):772-773.
PMID: 37483067
No abstract available.
3.
Hamid N, Jorde U, Reisman M, Latib A, Lim D, Joseph S, et al.
J Card Fail
. 2023 Mar;
29(7):1046-1055.
PMID: 36958391
Background: Left ventricular (LV) volume reshaping reduces myocardial wall stress and may induce reverse remodeling in patients with heart failure with reduced ejection fraction. The AccuCinch Transcatheter Left Ventricular Restoration...
4.
Litwin S, Komtebedde J, Hu M, Burkhoff D, Hasenfuss G, Borlaug B, et al.
JACC Heart Fail
. 2023 Mar;
11(8 Pt 2):1103-1117.
PMID: 36939661
Background: Many patients with heart failure and preserved ejection fraction have no overt volume overload and normal resting left atrial (LA) pressure. Objectives: This study sought to characterize patients with...
5.
Jeger R, Kaiser C, Mangner N, Kleber F, Scheller B
Clin Res Cardiol
. 2020 Jun;
110(2):307-311.
PMID: 32500165
No abstract available.
6.
Jeger R, Eccleshall S, Wan Ahmad W, Ge J, Poerner T, Shin E, et al.
JACC Cardiovasc Interv
. 2020 Jun;
13(12):1391-1402.
PMID: 32473887
Although drug-eluting stents are still the default interventional treatment of coronary artery disease, drug-coated balloons (DCBs) represent a novel alternative therapeutic strategy in certain anatomic conditions. The effect of DCBs...
7.
Scheller B, Vukadinovic D, Jeger R, Rissanen T, Scholz S, Byrne R, et al.
J Am Coll Cardiol
. 2020 Mar;
75(9):1017-1028.
PMID: 32138961
Background: Drug-coated balloons (DCBs) are accepted treatment strategies for coronary in-stent restenosis and are under clinical investigation for lesions without prior stent implantation. A recently published meta-analysis suggested an increased...
8.
9.
Kleber F, Hauschild T, Schulz A, Winkelmann A, Bruch L
Circ J
. 2017 Apr;
81(10):1484-1489.
PMID: 28450663
Background: Despite several negative prospective randomized trials on the efficacy of patent foramen ovale (PFO) occlusion, the discussion on indications is ongoing. Because the incidence of paradoxical coronary embolism through...
10.
Koln P, Scheller B, Liew H, Rissanen T, Wan Ahmad W, Weser R, et al.
Int J Cardiol
. 2016 Oct;
225:262-267.
PMID: 27741486
Background: Chronic total occlusions remain one of the biggest challenges for interventional cardiologists and the high risk of restenosis and stent thrombosis is still a major problem. Drug-coated balloons showed...